Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
40–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female (women of non-childbearing potential) subjects between the ages of 40 and 80 years, inclusive with a diagnosis of moderate COPD (GOLD, 2007 update) and who meet the following criteria for GOLD stage II disease
Body Mass Index (BMI) of less than 35.5 kg/m2; and a total body weight \>40 kg (88 lbs).
Current smokers, or ex-smokers who have abstained from smoking for at least 6 months
You may not be if
Subjects having more than 2 exacerbations requiring treatment with oral steroids or hospitalization for the treatment of COPD in the previous year.
History of lower respiratory tract infection or significant disease instability during the month preceding screening or during the period between screening and randomization.
Clareo Health | A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease
